Skip to main content
Login
Contact
Subscribe
Search form
Search
The Punxsutawney Spirit
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Ascendis Pharma Ads
(NQ:
ASND
)
156.90
USD
-5.11 (-3.15%)
Streaming Delayed Price
Updated: 3:18 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Ascendis Pharma Ads
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Visen Pharma Closes $150 Million Financing for Endocrine Drugs
January 12, 2021
Shanghai 's Visen Pharma closed a $150 million Series B financing to develop novel endocrine drugs in a round led by Sequoia China . In 2018, Visen was formed by Ascendis Pharma A/S of Denmark and an...
From
ChinaBio® Today
Ascendis Pharma A/S Provides Vision 3x3 Update at 39th Annual J.P. Morgan Healthcare Conference
January 10, 2021
From
GlobeNewswire News Releases
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China
January 08, 2021
VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for patients in Greater China, announced today the...
From
PR Newswire
Ascendis Pharma A/S Announces Equity Investment in VISEN Pharmaceuticals
January 08, 2021
From
GlobeNewswire News Releases
VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China
January 07, 2021
- TransCon ™ C-Type Natriuretic Peptide (CNP), an investigational once-weekly long-acting prodrug of CNP, is ready for Phase 2 Clinical Trial in China -
From
PR Newswire
Ascendis Pharma A/S Announces Participation in 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021
From
GlobeNewswire News Releases
A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Final Trading Session Of 2020
December 31, 2020
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade on the last trading day of 2020. Markets closed ...
Tags
Futures
Pre/Market Outlook
AZN
From
Benzinga
5 Stocks To Watch For December 31, 2020
December 31, 2020
Some of the stocks that may grab investor focus today are: S&P Dow Jones Indices reported that Enphase Energy Inc. (NASDAQ: ...
Tags
ASND
FCPT
News
From
Benzinga
Ascendis Pharma A/S Announces Filing of Investigational New Drug Application to Initiate TransCon™ TLR7/8 Agonist Clinical Program
December 30, 2020
From
GlobeNewswire News Releases
Benzinga's Top Upgrades, Downgrades For December 17, 2020
December 17, 2020
Upgrades For CAE Inc (NYSE:CAE), Bank of America upgraded the previous rating of Neutral to Buy. CAE earned $0.10 in the ...
Tags
MDB
STL
INDB
From
Benzinga
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
December 15, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
EIDX
ARVN
STOK
From
Benzinga
Ascendis Pharma A/S Announces Planned Board Transition
December 14, 2020
From
GlobeNewswire News Releases
Stocks That Hit 52-Week Highs On Monday
December 14, 2020
Monday's morning session saw 240 companies set new 52-week highs. Key Facts: The largest company by market cap to ...
Tags
HLIO
MEOH
R
From
Benzinga
Stocks That Hit 52-Week Highs On Friday
December 11, 2020
This morning 167 companies reached new 52-week highs. Noteables: Walt Disney (NYSE: DIS) was the largest firm on a ...
Tags
CCJ
TGTX
AHCO
From
Benzinga
Ascendis Pharma A/S Announces Participation at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
November 25, 2020
From
GlobeNewswire News Releases
Ascendis Pharma Earns Relative Strength Rating Upgrade
November 23, 2020
Ascendis Pharma shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
From
Investor's Business Daily
10 Biggest Price Target Changes For Friday
November 13, 2020
Raymond James raised the price target for Costco Wholesale Corporation (NASDAQ: COST) from $365 to $405. Costco shares rose 0.1% to ...
Tags
Small Cap
Price Target Changes
DRI
From
Benzinga
Ascendis Pharma A/S to Host Virtual Oncology R&D Day on Friday, November 20
November 11, 2020
From
GlobeNewswire News Releases
Recap: Ascendis Pharma Q3 Earnings
November 11, 2020
Shares of Ascendis Pharma (NASDAQ:ASND) were flat in after-market trading after the company reported Q3 results. Quarterly ...
Tags
Earnings
Benzinga
ASND
From
Benzinga
Ascendis Pharma A/S Reports Third Quarter 2020 Financial Results
November 11, 2020
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
November 11, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CYCC
ESPR
CODX
From
Benzinga
Earnings Scheduled For November 11, 2020
November 11, 2020
Companies Reporting Before The Bell • Air Products & Chemicals (NYSE:APD) is projected to report quarterly ...
Tags
NEPT
BEDU
News
From
Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
November 08, 2020
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ...
Tags
NAVB
IOVA
LIFE
From
Benzinga
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
November 05, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CHRS
VRTX
EXEL
From
Benzinga
Stocks That Hit 52-Week Highs On Wednesday
November 04, 2020
This morning 118 companies reached new 52-week highs. Noteworthy Points: Alphabet (NASDAQ: GOOG) was the company with ...
Tags
RCM
FSV
ZEN
From
Benzinga
Ascendis Pharma A/S Appoints Dr. Mark A. Bach as Senior Vice President of Clinical Development and Medical Affairs for Endocrinology Rare Diseases
November 03, 2020
From
GlobeNewswire News Releases
Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11
November 02, 2020
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
October 28, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
SPRB
GH
BVXV
From
Benzinga
Human Growth Hormone Deficiency (GHD) Drugs Market : Facts, Figures and Analytical Insights 2020-2023
October 27, 2020
Harrisburg, NC -- (SBWIRE) -- 10/27/2020 -- The Human Growth Hormone Deficiency (GHD) Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry...
From
SBWire - Latest Press Releases
Ascendis Pharma A/S Receives Orphan Designation for TransCon™ PTH for Treatment of Hypoparathyroidism in Europe
October 23, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.